TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08915 XX ID T08915 XX DT 12.05.2006 (created); kar. DT 06.12.2010 (updated); pum. CO Copyright (C), QIAGEN. XX FA Smad5 XX SY Smad-5. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G002405 Smad5. XX CL C0041; SMAD. XX SZ 465 AA; 52.2 kDa (cDNA) (calc.). XX SQ MTSMASLFSFTSPAVKRLLGWKQGDEEEKWAEKAVDALVKKLKKKKGAMEELEKALSSPG SQ QPSKCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLDICEFPFGSKQKE SQ VCINPYHYKRVESPVLPPVLVPRHNEFNPQHSLLVQFRNLSHNEPHMPQNATFPDSFHQP SQ NNAPFPLSPNSPYPPSPASSTYPNSPASSGPGSPFQLPADTPPPAYMPPDDQMAPDNSQP SQ MDTSSNMIPQTMPSISSRDVQPVAYEEPKHWCSIVYYELNNRVGEAFHASSTSVLVDGFT SQ DPSNNKSRFCLGLLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSSIFVQSRNC SQ NFHHGFHPTTVCKIPSSCSLKIFNNQEFAQLLAQSVNHGFEAVYELTKMCTIRMSFVKGW SQ GAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLTQMGSPLNPISSVS XX SC translated from EMBL #AF063006 XX FT 1 132 MH1 domain [1]. FT 13 137 PS51075; MH1. FT 26 135 SM00523; dwAneu5. FT 28 132 PF03165; MH1 domain. FT 133 263 Linker region [1]. FT 264 461 MH2 domain [1]. FT 265 443 PF03166; MH2 domain. FT 269 441 SM00524; DWB. FT 271 465 PS51076; MH2. FT 462 465 SSXS motif [1]. XX IN T09289 HOXA13; mouse, Mus musculus. IN T09291 HOXD13; mouse, Mus musculus. IN T11119 SIP1; mouse, Mus musculus. XX DR TRANSPATH: MO000081400. DR EMBL: AF063006; AF063006. DR EMBL: U77638; MMU77638. DR UniProtKB: P97454; P70341. XX RN [1]; RE0015120. RX PUBMED: 9076683. RA Meersseman G., Verschueren K., Nelles L., Blumenstock C., Kraft H., Wuytens G., Remacle J., Kozak C.A., Tylzanowski P., Niehrs C., Huylebroeck D. RT The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation RL Mech. Dev. 61:127-140 (1997). RN [2]; RE0015603. RA Chang H., Kraft H., Verschueren K., Wang P., Huylebroeck D., Matzuk M. M. RT Genomic organization and expression of mouse Smad5 RL direct submission (EMBL) : (). RN [3]; RE0015671. RX PUBMED: 10079220. RA Yang X., Castilla L. H., Xu X., Li C., Gotay J., Weinstein M., Liu P. P., Deng C.-X. RT Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5 RL Development 126:1571-1580 (1999). RN [4]; RE0017601. RX PUBMED: 10400677. RA Verschueren K., Remacle J. E., Collart C., Kraft H., Baker B. S., Tylzanowski P., Nelles L., Wuytens G., Su M. T., Bodmer R., Smith J. C., Huylebroeck D. RT SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. RL J. Biol. Chem. 274:20489-20498 (1999). RN [5]; RE0018465. RX PUBMED: 10504300. RA Ebisawa T., Tada K., Kitajima I., Tojo K., Sampath T. K., Kawabata M., Miyazono K., Imamura T. RT Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation RL J. Cell Sci. 112:3519-3527 (1999). RN [6]; RE0020663. RX PUBMED: 10224135. RA Ishisaki A., Yamato K., Hashimoto S., Nakao A., Tamaki K., Nonaka K., ten Dijke P., Sugino H., Nishihara T. RT Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells RL J. Biol. Chem. 274:13637-13642 (1999). RN [7]; RE0027996. RX PUBMED: 11278410. RA Sasaki A., Masuda Y., Ohta Y., Ikeda K., Watanabe K. RT Filamin associates with Smads and regulates transforming growth factor-beta signaling. RL J. Biol. Chem. 276:17871-7 (2001). RN [8]; RE0048182. RX PUBMED: 16087734. RA Williams T. M., Williams M. E., Heaton J. H., Gelehrter T. D., Innis J. W. RT Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability. RL Nucleic Acids Res. 33:4475-4484 (2005). XX //